Cargando…
真实世界中伊马替尼在BCR-ABL阳性急性淋巴细胞白血病中的应用
OBJECTIVE: To explore the efficacy and prognostic factors of imatinib (IM) combined with chemotherapy for BCR-ABL gene positive acute lymphoblastic leukemia (ALL). METHODS: A total of 209 BCR-ABL(+)ALL patients treated with imatinib plus chemotherapy from April 2003 to August 2015 were enrolled in t...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364881/ https://www.ncbi.nlm.nih.gov/pubmed/27801322 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.10.014 |